Clinical Improvements as Predictors of Improvements in Patient-Reported Outcomes: Post Hoc Analysis of a Randomized, Open-Label Study of Etanercept in Latin American Patients with Rheumatoid Arthritis
Generoso Guerra Bautista,1 Ricardo Machado Xavier,2 Maria de la Vega,3 J Abraham Simón-Campos,4 Gastón Solano,5 Ronald D Pedersen,6 Bonnie Vlahos,6 Cecilia Borlenghi7 1Centro de Investigación Marbella, Paitilla Panamá, Panamá; 2Hospital de Cl&am...
Guardado en:
Autores principales: | Guerra Bautista G, Xavier RM, de la Vega M, Simón-Campos JA, Solano G, Pedersen RD, Vlahos B, Borlenghi C |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c4943f7c47134a46984caa97ba8347ed |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Drug-induced cutaneous vasculitis developing during Etanercept treatment for rheumatoid arthritis
por: Maria N. Chamurlieva, et al.
Publicado: (2021) -
Clinical Outcomes in Iraqi Patients with Rheumatoid Arthritis Following Earlier or Later Treatment with Etanercept
por: Al-Ani N, et al.
Publicado: (2021) -
Association between ultrasound images and patient-reported outcomes in the treatment of rheumatoid arthritis: a retrospective study
por: Masao Nawata, et al.
Publicado: (2021) -
Development of the Rheumatoid Arthritis Distress Scale (RADS): a new tool to identify disease-specific distress in patients with Rheumatoid Arthritis
por: Linda Silke, et al.
Publicado: (2021) -
Clinical and serological characteristics of Ecuadorian patients with rheumatoid arthritis
por: Ríos C, et al.
Publicado: (2017)